Tuberoinfundibular peptide of 39 residues (TIP39) signaling modulates acute and tonic nociception

Experimental Neurology

Volumn 226, Issue 1, 2010, Pages 68-83

  Dimitrov, Eugene L ^a   Petrus, Emily ^a,b   Usdin, Ted B ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b Bldg 142   (United States)

Author keywords

Descending inhibition; Endocannabinoid; Knockout mouse; Nociception; Pain; Stress induced analgesia; Supraspinal

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CELL PROTEIN; NALOXONE; PARATHYROID HORMONE RECEPTOR 2; RIMONABANT; TUBEROINFUNDIBULAR PEPTIDE OF 39 RESIDUE; UNCLASSIFIED DRUG; AMIDASE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AFFECTING AGENT; FATTY-ACID AMIDE HYDROLASE; FORMALDEHYDE; MESSENGER RNA; NARCOTIC ANTAGONIST; NEUROPEPTIDE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; SLC17A6 PROTEIN, MOUSE; TUBEROINFUNDIBULAR PEPTIDE 39; VESICULAR GLUTAMATE TRANSPORTER 2;

AMYGDALOID NUCLEUS; ANALGESIA; ANIMAL BEHAVIOR; ANTINOCICEPTION; ARTICLE; BRAIN REGION; HOT PLATE TEST; HYPOALGESIA; LATENT PERIOD; MUTATION; NOCICEPTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; STIMULUS RESPONSE; TAIL FLICK TEST; THERMAL STIMULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DIAGNOSTIC USE; DRUG EFFECTS; GENETICS; IN SITU HYBRIDIZATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRASPINAL DRUG ADMINISTRATION; KNOCKOUT MOUSE; MALE; MENTAL STRESS; METABOLISM; MOUSE; PAIN; PAIN MEASUREMENT; PAIN RECEPTOR; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; SIGNAL TRANSDUCTION; SYNAPSE;

AMIDOHYDROLASES; ANIMALS; ENDOCANNABINOIDS; FORMALDEHYDE; IN SITU HYBRIDIZATION; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MALE; MICE; MICE, KNOCKOUT; NALOXONE; NARCOTIC ANTAGONISTS; NEUROPEPTIDES; NOCICEPTORS; PAIN; PAIN MEASUREMENT; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; RECEPTOR, PARATHYROID HORMONE, TYPE 2; RNA, MESSENGER; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; SYNAPSES; VESICULAR GLUTAMATE TRANSPORT PROTEIN 2; CANNABINOID RECEPTOR MODULATORS;

EID: 77957806153     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2010.08.004     Document Type: Article

References (72)

1. Almeida T.F., Roizenblatt S., Tufik S. Afferent pain pathways: a neuroanatomical review. Brain Res. 2004, 1000:40-56.
2. Bago A.G., Dimitrov E., Saunders R., Seress L., Palkovits M., Usdin T.B., Dobolyi A. Parathyroid hormone 2 receptor and its endogenous ligand tuberoinfundibular peptide of 39 residues are concentrated in endocrine, viscerosensory and auditory brain regions in macaque and human. Neuroscience 2009, 162:128-147.
3. Bannon A.W., Malmberg A.B. Models of Nociception: Hot-Plate, Tail-Flick, and Formalin Tests in Rodents. Current Protocols in Neuroscience 2007, 41. 8.9.1-8.9.16.
4. Basbaum A.I., Bautista D.M., Scherrer G., Julius D. Cellular and molecular mechanisms of pain. Cell 2009, 139:267-284.
5. Behar V., Pines M., Nakamoto C., Greenberg Z., Bisello A., Stueckle S.M., Bessalle R., Usdin T.B., Chorev M., Rosenblatt M., Suva L.J. The human PTH2 receptor: binding and signal transduction properties of the stably expressed recombinant receptor. Endocrinology 1996, 137:2748-2757.
6. Cliffer K.D., Burstein R., Giesler G.J. Distributions of spinothalamic, spinohypothalamic, and spinotelencephalic fibers revealed by anterograde transport of PHA-L in rats. J. Neurosci. 1991, 11:852-868.
7. Connell K., Bolton N., Olsen D., Piomelli D., Hohmann A.G. Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia. Neurosci. Lett. 2006, 397:180-184.
8. De Vry J., Jentzsch K.R., Kuhl E., Eckel G. Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development. Behav. Pharmacol. 2004, 15:1-12.
9. Della Penna K., Kinose F., Sun H., Koblan K.S., Wang H. Tuberoinfundibular peptide of 39 residues (TIP39): molecular structure and activity for parathyroid hormone 2 receptor. Neuropharmacology 2003, 44:141-153.
10. Dickenson A.H., Sullivan A.F. Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurones. Neurosci. Lett. 1987, 83:207-211.
11. Dimitrov E., Usdin T.B. Tuberoinfundibular peptide Of 39 residues modulates the mouse hypothalamic-pituitary-adrenal axis via paraventricular glutamatergic neurons. J. Comp. Neurol. 2010, 518:4375-4394.
12. Dobolyi A., Ueda H., Uchida H., Palkovits M., Usdin T.B. Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39 residues in nociception. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:1651-1656.
13. Dobolyi A., Palkovits M., Bodnar I., Usdin T.B. Neurons containing tuberoinfundibular peptide of 39 residues project to limbic, endocrine, auditory and spinal areas in rat. Neuroscience 2003, 122:1093-1105.
14. Dobolyi A., Palkovits M., Usdin T.B. Expression and distribution of tuberoinfundibular peptide of 39 residues in the rat central nervous system. J. Comp. Neurol. 2003, 455:547-566.
15. Dobolyi A., Irwin S., Wang J., Usdin T.B. The distribution and neurochemistry of the parathyroid hormone 2 receptor in the rat hypothalamus. Neurochem. Res. 2006, 31:227-236.
16. Dobolyi A., Palkovits M., Usdin T.B. The TIP39-PTH2 receptor system: unique peptidergic cell groups in the brainstem and their interactions with central regulatory mechanisms. Prog. Neurobiol. 2010, 90:29-59.
17. Domenici M.R., Azad S.C., Marsicano G., Schierloh A., Wotjak C.T., Dodt H.U., Zieglgansberger W., Lutz B., Rammes G. Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission. J. Neurosci. 2006, 26:5794-5799.
18. Egertova M., Cravatt B.F., Elphick M.R. Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience 2003, 119:481-496.
19. Faber C.A., Dobolyi A., Sleeman M., Usdin T.B. Distribution of tuberoinfundibular peptide of 39 residues and its receptor, parathyroid hormone 2 receptor, in the mouse brain. J. Comp. Neurol. 2007, 502:563-583.
20. Fegley D.B., Holmes A., Riordan T., Faber C.A., Weiss J.R., Ma S., Batkai S., Pacher P., Dobolyi A., Murphy A., Sleeman M.W., Usdin T.B. Increased fear- and stress-related anxiety-like behavior in mice lacking tuberoinfundibular peptide of 39 residues. Genes Brain Behav. 2008, 7:933-942.
21. Fields H.L., Heinricher M.M. Anatomy and physiology of a nociceptive modulatory system. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1985, 308:361-374.
22. Fox R.J., Sorenson C.A. Bilateral lesions of the amygdala attenuate analgesia induced by diverse environmental challenges. Brain Res. 1994, 648:215-221.
23. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 2008, Academic Press, New York, NY.
24. Goncalves L., Silva R., Pinto-Rriberio F., Pego J.M., Bessa J.M., Petrovaara A., Sousa N., Almeida A. Neuropathic pain is associated with depressive behaviour and induces neuroplasticity in the amygdala of the rat. Exp. Neurol. 2008, 213:48-56.
25. Goold C.P., Usdin T.B., Hoare S.R. Regions in rat and human parathyroid hormone (PTH) 2 receptors controlling receptor interaction with PTH and with antagonist ligands. J. Pharmacol. Exp. Ther. 2001, 299:678-690.
26. Gough A.L., Olley J.E. delta9-Tetrahydrocannabinol and the extrapyramidal system. Psychopharmacology (Berl) 1977, 54:87-99.
27. Hohmann A.G., Suplita R.L., Bolton N.M., Neely M.H., Fegley D., Mangieri R., Krey J.F., Walker J.M., Holmes P.V., Crystal J.D., Duranti A., Tontini A., Mor M., Tarzia G., Piomelli D. An endocannabinoid mechanism for stress-induced analgesia. Nature 2005, 435:1108-1112.
28. Hunskaar S., Hole K. The formalin test in mice: dissociation between inflamatory and non-inflamatory pain. Pain 1986, 30:103-114.
29. Jensen T.S., Yaksh T.L. Comparison of antinociceptive action of morphine in the periaqueductal gray, medial and paramedial medulla in rat. Brain Res. 1986, 363:99-113.
30. Jhaveri M.D., Richardson D., Kendall D.A., Barrett D.A., Chapman V. Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain. J. Neurosci. 2006, 26:13318-13327.
31. Kaneko T., Fujiyama F. Complementary distribution of vesicular glutamate transporters in the central nervous system. Neurosci. Res. 2002, 42:243-250.
32. Katona I., Rancz E.A., Acsady L., Ledent C., Mackie K., Hajos N., Freund T.F. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J. Neurosci. 2001, 21:9506-9518.
33. Katona I., Urban G.M., Wallace M., Ledent C., Jung K.M., Piomelli D., Mackie K., Freund T.F. Molecular composition of the endocannabinoid system at glutamatergic synapses. J. Neurosci. 2006, 26:5628-5637.
34. Kuo J., Usdin T.B. Development of a rat parathyroid hormone 2 receptor antagonist. Peptides 2007, 28:887-892.
35. LaBuda C.J., Usdin T.B. Tuberoinfundibular peptide of 39 residues decreases pain-related affective behavior. Neuroreport 2004, 15:1779-1782.
36. LaBuda C.J., Dobolyi A., Usdin T.B. Tuberoinfundibular peptide of 39 residues produces anxiolytic and antidepressant actions. Neuroreport 2004, 15:881-885.
37. Lewis J.W., Cannon J.T., Liebeskind J.C. Opioid and nonopioid mechanisms of stress analgesia. Science 1980, 208:623-625.
38. Long J.Z., Nomura D.K., Vann R.E., Walentiny D.M., Booker L., Jin X., Burston J.J., Sim-Selley L.J., Lichtman A.H., Wiley J.L., Cravatt B.F. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20270-20275.
39. Mailleux P., Vanderhaeghen J.J. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 1992, 48:655-668.
40. Maione S., Bisogno T., de Novellis V., Palazzo E., Cristino L., Valenti M., Petrosino S., Guglielmotti V., Rossi F., Di Marzo V. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors. J. Pharmacol. Exp. Ther. 2006, 316:969-982.
41. Manning B.H., Merin N.M., Meng I.D., Amaral D.G. Reduction in opioid- and cannabinoid-induced antinociception in rhesus monkeys after bilateral lesions of the amygdaloid complex. J. Neurosci. 2001, 21:8238-8246.
42. Marsicano G., Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci. 1999, 11:4213-4225.
43. Martin B.R., Compton D.R., Thomas B.F., Prescott W.R., Little P.J., Razdan R.K., Johnson M.R., Melvin L.S., Mechoulam R., Ward S.J. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol. Biochem. Behav. 1991, 40:471-478.
44. Martin W.J., Coffin P.O., Attias E., Balinsky M., Tsou K., Walker J.M. Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections. Brain Res. 1999, 822:237-242.
45. Martini L., Thompson D., Kharazia V., Whistler J.L. Differential regulation of behavioral tolerance to WIN55,212-2 by GASP1. Neuropsychopharmacology 2010, 35:1363-1373.
46. Mason P. Ventromedial medulla: pain modulation and beyond. J. Comp. Neurol. 2005, 493:2-8.
47. Matsumoto M., Kondo S., Usdin T.B., Ueda H. Parathyroid hormone 2 receptor is a functional marker of nociceptive myelinated fibers responsible for neuropathic pain. J. Neurochem. 2010, 112:521-530.
48. Millan M.J. Descending control of pain. Prog. Neurobiol. 2002, 66:355-474.
49. Mogil J.S., Sternberg W.F., Balian H., Liebeskind J.C., Sadowski B. Opioid and nonopioid swim stress-induced analgesia: a parametric analysis in mice. Physiol. Behav. 1996, 59:123-132.
50. Oviedo A., Glowa J., Herkenham M. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study. Brain Res. 1993, 616:293-302.
51. Palkovits M., Helfferich F., Dobolyi A., Usdin T.B. Acoustic stress activates tuberoinfundibular peptide of 39 residues neurons in the rat brain. Brain Struct. Funct. 2009, 214:15-23.
52. Rogan M.T., Staubli U.V., LeDoux J.E. Fear conditioning induces associative long-term potentiation in the amygdala. Nature 1997, 390:604-607.
53. Ross G., Engel P., Abdallah Y., Kummer W., Schluter K.D. Tuberoinfundibular peptide of 39 residues: a new mediator of cardiac function via nitric oxide production in the rat heart. Endocrinology 2005, 146:2221-2228.
54. Sanudo-Pena M.C., Tsou K., Walker J.M. Motor actions of cannabinoids in the basal ganglia output nuclei. Life Sci. 1999, 65:703-713.
55. Schafer M.K., Varoqui H., Defamie N., Weihe E., Erickson J.D. Molecular cloning and functional identification of mouse vesicular glutamate transporter 3 and its expression in subsets of novel excitatory neurons. J. Biol. Chem. 2002, 277:50734-50748.
56. Sim-Selley L.J., Martin B.R. Effect of chronic administration of R-(+)-[2, 3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1, 2, 3-de]-1, 4-b enzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55, 212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice. J. Pharmacol. Exp. Ther. 2002, 303:36-44.
57. Sugimura Y., Murase T., Ishizaki S., Tachikawa K., Arima H., Miura Y., Usdin T.B., Oiso Y. Centrally administered tuberoinfundibular peptide of 39 residues inhibits arginine vasopressin release in conscious rats. Endocrinology 2003, 144:2791-2796.
58. Suplita R.L., Gutierrez T., Fegley D., Piomelli D., Hohmann A.G. Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia. Neuropharmacology 2006, 50:372-379.
59. Terman G.W., Shavit Y., Lewis J.W., Cannon J.T., Liebeskind J.C. Intrinsic mechanisms of pain inhibition: activation by stress. Science 1984, 226:1270-1277.
60. Terman G.W., Lewis J.W., Liebeskind J.C. Two opioid forms of stress analgesia: studies of tolerance and cross-tolerance. Brain Res. 1986, 368:101-106.
61. Terman G.W., Morgan M.J., Liebeskind J.C. Opioid and non-opioid stress analgesia from cold water swim: importance of stress severity. Brain Res. 1986, 372:167-171.
62. Todd A.J., Hughes D.I., Polgar E., Nagy G.G., Mackie M., Ottersen O.P., Maxwell D.J. The expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in neurochemically defined axonal populations in the rat spinal cord with emphasis on the dorsal horn. Eur. J. Neurosci. 2003, 17:13-27.
63. Usdin T.B., Hilton J., Vertesi T., Harta G., Segre G., Mezey E. Distribution of the parathyroid hormone 2 receptor in rat: immunolocalization reveals expression by several endocrine cells. Endocrinology 1999, 140:3363-3371.
64. Usdin T.B., Hoare S.R., Wang T., Mezey E., Kowalak J.A. TIP39: a new neuropeptide and PTH2-receptor agonist from hypothalamus. Nat. Neurosci. 1999, 2:941-943.
65. Valverde O., Ledent C., Beslot F., Parmentier M., Roques B.P. Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors. Eur. J. Neurosci. 2000, 2:533-539.
66. Varoqui H., Schafer M.K., Zhu H., Weihe E., Erickson J.D. Identification of the differentiation-associated Na+/PI transporter as a novel vesicular glutamate transporter expressed in a distinct set of glutamatergic synapses. J. Neurosci. 2002, 22:142-155.
67. Wang T., Palkovits M., Rusnak M., Mezey E., Usdin T.B. Distribution of parathyroid hormone-2 receptor-like immunoreactivity and messenger RNA in the rat nervous system. Neuroscience 2000, 100:629-649.
68. Wang J., Palkovits M., Usdin T.B., Dobolyi A. Forebrain projections of tuberoinfundibular peptide of 39 residues (TIP39)-containing subparafascicular neurons. Neuroscience 2006, 138:1245-1263.
69. Ward H.L., Small C.J., Murphy K.G., Kennedy A.R., Ghatei M.A., Bloom S.R. The actions of tuberoinfundibular peptide on the hypothalamo-pituitary axes. Endocrinology 2001, 142:3451-3456.
70. Willis W.D., Westlund K.N. Neuroanatomy of the pain system and of the pathways that modulate pain. J. Clin. Neurophysiol. 1997, 14:2-31.
71. Yeomans D.C., Pirec V., Proudfit H.K. Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: behavioral evidence. Pain 1996, 68:133-140.
72. Zimmer A., Zimmer A.M., Hohmann A.G., Herkenham M., Bonner T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:5780-5785.